The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
Authors
Keywords
-
Journal
Analytical Cellular Pathology
Volume 2020, Issue -, Pages 1-17
Publisher
Hindawi Limited
Online
2020-12-12
DOI
10.1155/2020/2872479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma
- (2019) Tiziana Annese et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation
- (2018) Marcel Oliver Schmidt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
- (2018) Julia Elisabeth Fromme et al. Oncotarget
- Eldecalcitol (ED-71), an analog of 1α,25(OH)2D3, inhibits the growth of squamous cell carcinoma (SCC) cells in vitro and in vivo by down-regulating expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) and FGF-2
- (2017) T. Shintani et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Fibroblast growth factor receptors in breast cancer
- (2017) Shuwei Wang et al. TUMOR BIOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells
- (2016) Nobuhisa Takase et al. CANCER LETTERS
- Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy.
- (2016) S. Saichaemchan et al. CURRENT MOLECULAR MEDICINE
- Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas
- (2016) T. Shintani et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer
- (2016) W. S. Brown et al. MOLECULAR CANCER THERAPEUTICS
- Blocking the FGF/FGFR system as a two-compartment antiangiogenic/antitumor approach in cancer therapy
- (2016) Arianna Giacomini et al. PHARMACOLOGICAL RESEARCH
- miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
- (2016) Y Hu et al. Cell Death & Disease
- Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
- (2016) Young Kwang Chae et al. Oncotarget
- Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
- (2016) Mohamed R. Akl et al. Oncotarget
- The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
- (2015) Roberto Ronca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation
- (2015) Nobuhiro Ueno et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF
- (2015) Evelyn Fessler et al. Molecular Cancer
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma
- (2015) Seema Nayak et al. PLoS One
- Mechanisms of FGFR-mediated carcinogenesis
- (2012) Imran Ahmad et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of Fibroblast Growth Factor-Binding Protein–1 Expression on Angiogenesis and Wound Healing
- (2011) Elena Tassi et al. AMERICAN JOURNAL OF PATHOLOGY
- Current standard and trends in oesophageal cancer
- (2011) Florian Lordick EUROPEAN JOURNAL OF CANCER
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- Esophageal cancer: 5-year survival rate at south-east of Caspian sea of northern Iran
- (2011) AzadReza Mansourian et al. Journal of Cancer Research and Therapeutics
- Still waiting for predictive biomarkers in Barrett's oesophagus
- (2011) L. H. Moyes et al. JOURNAL OF CLINICAL PATHOLOGY
- Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration
- (2010) G Sonvilla et al. BRITISH JOURNAL OF CANCER
- Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
- (2010) E. M. Haugsten et al. MOLECULAR CANCER RESEARCH
- The Role of Fibroblast Growth Factors in Tumor Growth
- (2009) M. Korc et al. CURRENT CANCER DRUG TARGETS
- Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
- (2009) Jing Qing et al. JOURNAL OF CLINICAL INVESTIGATION
- FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations
- (2009) Sarah Lott et al. MODERN PATHOLOGY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started